IOTOD 2013’s programme focused on optimising the quality of care, safety issues in opioid dependence and managing complex patients.
The programme covered emerging issues such as minimising the risks associated with medication transfers, recognising drug–drug interactions, treating co-existing HCV, as well as practical approaches to drug addiction and pregnancy.
Chairs
Professor Sharon Walsh
Professor of Behavioral Science and Psychiatry Center on Drug and Alcohol Research, University of Kentucky
Lexington, KY, USA
Scientific Committee
Marc Auriacombe
Professor of Psychiatry and Addiction Medicine, University of Bordeaux
Bordeaux, France
Maurice Dematteis
Head of the Department of Addictions, University Hospital of Grenoble
Grenoble, France
John Marsden
Professor of Addiction Psychology, Addictions Department, King’s College London
London, UK
Nicholas Lintzeris
Drug and Alcohol Services, South-East Sydney Local Health District
Sydney, Australia
Speakers
Professor Elinore McCance-Katz
Professor of Psychiatry, University of California San Francisco
USA
Marc Auriacombe
Professor of Psychiatry and Addiction Medicine, University of Bordeaux
Bordeaux, France
Professor Michael Soyka
Medical Director, Psychiatric Hospital Meiringen
Meiringen, Switzerland
Dr Daniel Fuster
Internist, Addiction Unit, Universitari Germans Trias i Pujol
Badalona, Spain
Professor Seddon Savage
Director, Dartmouth Center on Addiction Recovery and Education
New Hampshire, USA
Dr Jenny Bearn
Consultant Psychiatrist/Honorary Senior Lecturer, South London and Maudsley NHS Foundation Trust and Institute of Psychiatry, King’s College London
London, UK
Dr Laurent Gourarier
Psychiatrist and Additcion Specialist, La Terrasse, Hôpital Maison Blanche
Paris, France
Professor Mark Haigney
Professor of Medicine and Pharmacology and Director of Cardiology, F Edward Hébert School of Medicine
Bethesda, MD, USA
Professor David Fiellin
Professor of Medicine, Investigative Medicine and Public Health, Yale University School of Medicine
USA
